HEART TEST LABORATORIES INC (HSCS)       0.8701  +0.09 (+11.38%)

0.8701  +0.09 (+11.38%)

US42254E1047 - Common Stock - Premarket: 1 +0.13 (+14.93%)

News Image
7 days ago - Heart Test Laboratories, Inc.

Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th

Southlake, Texas, Jan. 23, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on January 20th, 2023, by HeartSciences (NASDAQ: HSCS;...

News Image
10 days ago - Heart Test Laboratories, Inc.

HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th

Southlake, Texas, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...

News Image
26 days ago - Heart Test Laboratories, Inc.

HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive

Southlake, TX, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...

News Image
2 months ago - Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results

Patient Enrollment Close to Completion and Continue to Target FDA De Novo Resubmission Around Current Fiscal Year End...

News Image
2 months ago - Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results

Patient Enrollment Close to Completion and Continue to Target FDA De Novo Resubmission Around Current Fiscal Year End

News Image
2 months ago - Heart Test Laboratories, Inc.

HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms

Southlake, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...

News Image
2 months ago - Heart Test Laboratories, Inc.

HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022

Southlake, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...

News Image
2 months ago - Heart Test Laboratories, Inc.

HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022

Southlake, Texas, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...

News Image
3 months ago - Heart Test Laboratories, Inc.

HeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events

Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification

News Image
3 months ago - Heart Test Laboratories, Inc.

HeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events

Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification...

News Image
3 months ago - Heart Test Laboratories, Inc.

HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG

Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues

News Image
3 months ago - Heart Test Laboratories, Inc.

HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG

Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues...

News Image
3 months ago - Heart Test Laboratories, Inc.

HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction

Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including...

News Image
4 months ago - Heart Test Laboratories, Inc.

HeartSciences Granted U.S Patent for ECG Assessment of Heart Diastolic Function Using Artificial Intelligence

Patent continues to strengthen and expand IP portfolio...

News Image
5 months ago - Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2023 Financial Results

Nearing Completion of Patient Recruitment in FDA Pivotal Clinical Validation Study of MyoVista® Remains on Track for MyoVista® FDA De Novo Resubmission...

News Image
5 months ago - Heart Test Laboratories, Inc.

HeartSciences to Participate and Showcase the MyoVista at the Inauguration Ceremony of the Center for Innovation at Rutgers Robert Wood Johnson University Hospital

Southlake, Texas, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc d.b.a HeartSciences (NASDAQ: HSCS), a medical technology company...

News Image
5 months ago - Heart Test Laboratories, Inc.

HeartSciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Southlake, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...